Introduction
============

Chronic obstructive pulmonary disease (COPD) continues to be an important cause of morbidity, mortality, and health care costs worldwide. As the global population ages, the burden of COPD will increase in the years to come.[@b1-copd-10-667]--[@b3-copd-10-667] Numerous specialists and researchers have focused their efforts on COPD in an attempt to gain a better understanding of how comorbid diseases, different phenotypes, and risk factor affect the outcome of COPD patients. A great numbers of articles have been published annually and have given new insights into the mechanism or treatment of COPD.[@b4-copd-10-667]--[@b6-copd-10-667] However, there still exists a lack of knowledge regarding the quality of scientific yield in relation to this area.

It is generally believed that publications represent the central part of a research process. In medicine, the number of times a paper is cited by other authors has been established as a widely used and logical measure of how much academic influence it has had in its subject area. The reporting of this type of citation analysis is widespread in the medical literature.[@b7-copd-10-667]--[@b16-copd-10-667] One way to measure the academic importance of an article is the rate at which the work is quoted or referenced by other authors.[@b7-copd-10-667],[@b11-copd-10-667],[@b16-copd-10-667] The article referenced by another peer-reviewed article receives a "citation." The total number of citations that an article receives is not necessarily a measure of its academic quality or even its influence upon the practice of the author's or authors' peers.[@b17-copd-10-667] Nevertheless, it does testify to the readership of the particular article and the influence of the article in generating changes in practice, controversy, discussion, or further research. Citation is viewed as a direct measure of the recognition an article has received in its field. Citation analysis in specific journals and specific subject areas has become a popular method to assess the citation impact of a journal, article, or author.[@b8-copd-10-667],[@b10-copd-10-667]--[@b13-copd-10-667],[@b18-copd-10-667]--[@b23-copd-10-667]

The Institute for Scientific Information (ISI) has been collecting citation and other academic impact information since 1945 and has been available electronically since 1979. ISI (now a subsidiary of Thomson Corp) calls their newest journal citation system "Science Citation Index^®^ (SCI) Expanded," and it is one of the databases available under the banner of Web of Science. Citation data from peer-reviewed articles are indexed from more than 10,000 high-impact journals, not only from the sciences and social sciences but also, from the arts and humanities.

This search used the electronic version of this database to determine which published articles in medical journals have been cited most often by other authors, by ranking the 100 top-cited works. By analyzing characteristics of these articles, we intended to determine what qualities make a COPD article important to the specialty.

Materials and methods
=====================

On June 30, 2014, authors searched Web of Science and identified the 100 top-cited articles relating to COPD ([Table 1](#t1-copd-10-667){ref-type="table"}) published in professional journals from 1945 to date. The articles entitled using the terms "COPD" or "chronic obstructive pulmonary disease" or "chronic obstructive pulmonary diseases" were included in the research.

Each article in the most cited 100 was reviewed, and the basic information collected included authors, year of publications, source journal of the article, geographic origin of the authors, and study field (general internal medicine, respiratory system, cardiovascular system cardiology, immunology, microbiology, physiology, research experimental medicine, sports science, or surgery). The full texts were mainly selected by PubMed or ScienceDirect. In addition, other methods were also used to search for articles that were not found in the aforementioned database, for example, interlibrary lending and requests for help on the PubMed.cn website (<http://paper.pubmed.cn/>). This website is a Chinese language--based platform used by scholars to request and share literatures. Several articles were cited more often than others because of the difference in time since publication. Thus, a citation index was also determined for each article to control this error. The citation index was defined as the mean number of citation times per year.

Statistical analysis was performed using SPSS 17 (SPSS Inc., Chicago, IL, USA). Spearman correlation analysis was used to test the total citation times and number of citation times per year, with an alpha level of 0.05. Descriptive statistics were quantified as counts or percentages of parameters.

As this was a bibliometric analysis, it was not necessary to obtain Internal Review Board approval.

Results
=======

A total of 22,210 papers were identified in the initial search for the period from 1960 to present, with 12,098 published as "article" and 1,436 classified as "review". Among them, 623 articles were cited more than 100 times. One hundred selected articles were published from 1966 to 2010, of which about 55% were published after 2000. The mean number of citations was 450 (range 254 to 2,164), and seven papers were cited more than 1,000 times ([Table 1](#t1-copd-10-667){ref-type="table"}). Annual average number of citations were correlated by total number of citations (*r*~s~=0.659, *P*\<0.0001).

The most cited paper, published by Rabe et al[@b24-copd-10-667] in 2007, was an executive summary describing the global strategy for the diagnosis, management, and prevention of COPD. Interestingly, the second most cited paper, by Celli et al[@b25-copd-10-667] received 1,659 citations and was also a summary of standards for the diagnosis and treatment of patients with COPD, published in 2004. The third article, by Hogg et al[@b26-copd-10-667] was a randomized controlled trial (RCT) -- the paper proved that 1) progression of COPD is associated with the accumulation of inflammatory mucous exudates in the lumen and infiltration of the wall by innate and adaptive inflammatory immune cells that form lymphoid follicles, and 2) these changes are coupled to a repair or remodeling process that thickens the walls of these airways. The most recent paper came from 2010 and was cited 367 times. This paper[@b27-copd-10-667] proposed use of the "frequent exacerbation phenotype" to predict COPD exacerbations, implicating an important target of exacerbation-prevention strategies across the spectrum of disease severity. The last paper on the most cited list was a cohort study, authored by Marquis et al from 2002 and cited 254 times to date, which found that the midthigh muscle cross-sectional area was a better predictor of mortality than body mass index (BMI) in COPD patients; these findings suggest that the assessment of body composition may be useful in clinical practice.[@b28-copd-10-667]

The 100 top-cited articles were published in 18 journals, predominantly in American Journal of Respiratory and Critical Care Medicine (n=30), followed by European Respiratory Journal (n=14) and New England Journal of Medicine (n=12) ([Table 2](#t2-copd-10-667){ref-type="table"}).

The greatest number of top-cited articles were published in 1996, 2000, and 2002 (n=8 each). The least number of articles was published in the 1960s (n=1 \[decade\]). Articles on the list were divided into three periods, 1960 to 1989 (n=8), 1990 to 1999 (n=37), and after 2000 (n=55) ([Table 3](#t3-copd-10-667){ref-type="table"}).

The country origins of the articles included: the United States (n=38), England (n=34), Canada (n=20), Netherlands (n=12), Italy (n=10), Belgium (n=9), Spain (n=8), Denmark (n=7), Australia (n=6), and Scotland (n=5). The rest of the countries had less than five publications. [Table 4](#t4-copd-10-667){ref-type="table"} shows the distribution of top-cited articles over the countries of origin. Given some articles were authored with multiple sources of origin, especially those in the form of international research collaborations, the total number of countries of origin exceeded 100. The leading institutions are shown in [Table 5](#t5-copd-10-667){ref-type="table"}. Imperial College London was found to be the most productive institution (n=16), followed by the University of London (n=10) and GlaxoSmithKline (n=9).

Among the 100 top-cited articles in COPD, the overwhelming majority (n=63 each) were studies belonging to "general internal medicine" and "respiratory system", followed by two studies in "cardiovascular system cardiology". Other fields, like "immunology", "microbiology" and "physiology" only had one article each ([Table 6](#t6-copd-10-667){ref-type="table"}).

The top-cited papers were written by 749 authors and ranged from 1 to 70 per article. Three articles had one author, followed by eight articles with two authors, and eight articles with three authors. [Table 7](#t7-copd-10-667){ref-type="table"} presents a list of the most productive authors, showing that Barnes and Wedzicha each authored ten articles, followed by Vestbo (n=8), Jones (n=7), Buist (n=6), Calverley (n=6), Hogg (n=6), Anthonisen (n=5), Celli (n=5), Maltais (n=5), and Seemungal (n=5) ([Table 7](#t7-copd-10-667){ref-type="table"}).

Discussion
==========

In medical literature, the number of times other authors reference an article is one measure of the influence of the publication, and this type of citation analysis strategy is widely used as a bibliometric study. The evaluation of specialty-wide citation analyses has been reported in other areas of medicine.[@b7-copd-10-667]--[@b9-copd-10-667],[@b18-copd-10-667]--[@b21-copd-10-667],[@b23-copd-10-667] However, the establishment of a citation rank list across a specialty, comprising many journals specific to an area of medicine, is a more complex process than citation analysis for one journal, although such analyses have been reported in some other areas of medicine.[@b31-copd-10-667]--[@b34-copd-10-667]

In this review, researchers ranked the top 100 articles by number of citations, in the specialty of COPD. The top article had 2,164 citations. Seven papers were cited more than 1,000 times, of which three were summaries of the most well-known international COPD management guidelines, by different research institutions or in different periods. However, they all represented the latest achievements of COPD development in their period and have played profound influence in COPD treatment and research development around the world. While the third-place paper was classic RCT research, the findings created a new therapy targets for COPD treatment. The fourth paper also was classic; the authors proved a multidimensional grading system (the BODE \[BMI, airflow obstruction, dyspnea, and exercise\] index) assessing the respiratory and systemic expressions of COPD would better categorize and predict outcome in COPD patients than the forced expiratory volume in one second (FEV~1~). The fifth and sixth papers were specialized in the exploration of COPD drug therapy, and both of their groundbreaking discoveries have provided new directions for COPD treatment. In sum, the main reason for being so widely referenced is that the findings or conclusions reported in these papers have produced historical influence in COPD treatment and research history. However, every article on the list can be considered a citation "classic" by the frequently used, but somewhat arbitrary, marker of 100 pieces as the benchmark.[@b29-copd-10-667]

This review of the most cited articles in COPD may be worthwhile for several reasons. First, the observations suggest the authors of citation classics in COPD have produced more highly cited articles than many of their colleagues in other specialties. Second, this study has successfully identified several attributes of articles in citation, indicating that journal and country of origin are very important factors. Finally, this paper might be considered as the first report on the most cited papers in COPD.

The study characteristics revealed here echo those found in similar reviews. The majority of articles originated in the United States. This result is in line with previous studies and is in accordance with the reported strong influence of the United States in research related to health science,[@b8-copd-10-667],[@b12-copd-10-667],[@b14-copd-10-667] indicating that American authors may be at an advantage. On the contrary, in Asian countries, although the scientific research has achieved rapid development in recent years, authors did not have a place in the COPD research field since their contribution in research productivity was rather disappointing. European countries, like England, Netherlands, Italy, etc, also showed a higher productivity. This finding seems to conform to the phenomenon "the better the economic ranking of a country, the higher the quantity and quality of its biomedical publications".[@b30-copd-10-667]

Financial support from public foundations or commercial companies has evolved over time in response to changes in professional codes, laws, and markets. Public funds have given a great push to the development of medical research and public health. Industry-funded science has been widely debated because of the susceptibility to various kinds of biases. Nevertheless, it has played and will continue to play a critical role in the research process. Although this research did not analyze financial support separately, our findings showed that there was a commercial company ranked among the top-ten prolific institutions, which contributed a total of nine articles.

Although researchers were expecting a higher number, only 18% of the papers were review articles, whereas the majority were original research articles, which might be attributable to a preference for referencing experimental evidence rather than review articles or expert opinion.

It has been reported that scientific articles begin to be cited 1 or 2 years after publication and reach a maximum citation rate 7 to 10 years later after publication.[@b26-copd-10-667]--[@b28-copd-10-667] It has also been reported that the "older" articles are, the greater the likelihood that they have attained more citations, purely because their citable period was longer. However, in our study, the citation rate gradually rose over the last decade and is indicative of an increasing consideration for the field of COPD.

Authors have to acknowledge that our study has several possible methodological limitations. First and foremost, this survey was restricted with the word "COPD" or "chronic obstructive pulmonary disease" or "chronic obstructive pulmonary diseases" in their titles. In other words, some significant COPD articles published under other titles might not have been included, and it is possible that these were good-quality articles with a high number of citations. Second, the journals have different approaches to accept or reject a submitted manuscript. Thus, particular journals could have stricter selection criteria that might have affected the clinical applicability or quality of their publications. The criteria could be a reason why most top-cited papers were found in one journal. Also, there are some intrinsic problems in using this method alone to evaluate the academic importance of one article, an author's or authors' publications, or the performance of a journal overall. First, this type of citation analysis does not account for self-citation, citations in textbooks and lectures, and an author's or authors' potential preference to cite articles in the journal in which they seek to publish their work.[@b29-copd-10-667] Second, language of publication plays a major role, with an obvious bias for articles published in English language journals. Third, there are biases inherent in the age of the database as any articles published in the 19th or early 20th century would be excluded, which likely causes some true "classic" articles to be excluded. Finally, previous study[@b16-copd-10-667] would tell us that in a scientific community, there is a tendency for adherence to a paradigm. In this context, this would mean that there is "snowball effect" to citations and that other authors are more likely to cite it because of previous citations, rather than for its content or quality. Despite these obvious defects, the data presented here do provide insight into the achievement and development of COPD research over the past decades.
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###### 

The 100 most cited papers in COPD

  Rank   First author                      No of citations   Publication year   Citations/year   New rank[\*](#tfn1-copd-10-667){ref-type="table-fn"}   Rank   First author                          No of citations   Publication year   Citations/year   New rank[\*](#tfn1-copd-10-667){ref-type="table-fn"}   Rank   First author                        No of citations   Publication year   Citations/year   Newrank[\*](#tfn1-copd-10-667){ref-type="table-fn"}
  ------ --------------------------------- ----------------- ------------------ ---------------- ------------------------------------------------------ ------ ------------------------------------- ----------------- ------------------ ---------------- ------------------------------------------------------ ------ ----------------------------------- ----------------- ------------------ ---------------- -----------------------------------------------------
  1      Rabe KF[@b24-copd-10-667]         2,164             2007               270.50           1                                                      35     Gosselink R[@b66-copd-10-667]         407               1996               21.42            62                                                     69     Barnes PJ[@b99-copd-10-667]         303               2009               50.50            14
  2      Celli BR[@b25-copd-10-667]        1,659             2004               150.82           2                                                      36     Seemungal T[@b67-copd-10-667]         400               2001               28.57            46                                                     70     Jones PW[@b100-copd-10-667]         303               1997               16.83            80
  3      Hogg JC[@b26-copd-10-667]         1,246             2004               113.27           4                                                      37     Ito K[@b68-copd-10-667]               394               2005               39.40            25                                                     71     Montuschi P[@b101-copd-10-667]      301               2000               20.07            67
  4      Celli BR[@b35-copd-10-667]        1,177             2004               107.00           5                                                      38     Szafranski W[@b69-copd-10-667]        394               2003               32.83            35                                                     72     Mahler DA[@b102-copd-10-667]        297               1999               18.56            75
  5      Calverley PMA[@b36-copd-10-667]   1,146             2007               143.25           3                                                      39     Saetta M[@b70-copd-10-667]            383               1998               22.53            60                                                     73     Nava S[@b103-copd-10-667]           297               1998               17.47            78
  6      Anthonisen NR[@b37-copd-10-667]   1,129             1987               40.32            23                                                     40     Anthonisen NR[@b71-copd-10-667]       383               1986               13.21            93                                                     74     Cazzola M[@b104-copd-10-667]        296               2008               42.29            20
  7      Siafakas NM[@b38-copd-10-667]     1,006             1995               50.30            15                                                     41     Hogg JC[@b72-copd-10-667]             379               2004               34.45            33                                                     75     Monso E[@b105-copd-10-667]          293               1995               14.65            87
  8      Brochard L[@b39-copd-10-667]      834               1995               41.70            21                                                     42     Landbo C[@b73-copd-10-667]            379               1999               23.69            58                                                     76     Renzetti AD[@b106-copd-10-667]      292               1966               5.96             100
  9      Keatings VM[@b40-copd-10-667]     791               1996               41.63            22                                                     43     Soler-Cataluna JJ[@b74-copd-10-667]   373               2005               37.30            28                                                     77     Maltais F[@b107-copd-10-667]        289               1996               15.21            83
  10     Seemungal TAR[@b41-copd-10-667]   768               1998               45.18            17                                                     44     Kuwano K[@b75-copd-10-667]            372               1993               16.91            79                                                     78     Wilson DO[@b108-copd-10-667]        289               1989               11.12            95
  11     Burge PS[@b42-copd-10-667]        765               2000               51.00            12                                                     45     Hurst JR[@b27-copd-10-667]            367               2010               73.40            7                                                      79     Seneff MG[@b109-copd-10-667]        285               1995               14.25            90
  12     Tashkin DP[@b43-copd-10-667]      669               2008               95.57            6                                                      46     Lacasse Y[@b76-copd-10-667]           366               1996               19.26            72                                                     80     Scanlon PD[@b110-copd-10-667]       284               2000               18.93            74
  13     Donaldson GC[@b44-copd-10-667]    663               2002               51.00            13                                                     47     Saint S[@b77-copd-10-667]             366               1995               18.30            77                                                     81     Paggiaro PL[@b111-copd-10-667]      283               1998               16.65            81
  14     Barnes PJ[@b45-copd-10-667]       654               2000               43.60            19                                                     48     Barnes PJ[@b78-copd-10-667]           359               2008               51.29            11                                                     82     Celli BR[@b112-copd-10-667]         282               2008               40.29            24
  15     Gan WQ[@b46-copd-10-667]          597               2004               54.27            10                                                     49     Niewoehner DE[@b79-copd-10-667]       358               1999               22.38            61                                                     83     Vestbo J[@b113-copd-10-667]         279               1996               14.68            86
  16     Barnes PJ[@b47-copd-10-667]       556               2003               46.33            16                                                     50     Bernard S[@b80-copd-10-667]           358               1998               21.06            64                                                     84     Papi A[@b114-copd-10-667]           277               2006               30.78            42
  17     Cooper JD[@b48-copd-10-667]       555               1995               27.75            50                                                     51     Bourbeau J[@b81-copd-10-667]          357               2003               29.75            44                                                     85     Saetta M[@b115-copd-10-667]         277               2001               19.79            69
  18     Calverley P[@b49-copd-10-667]     540               2003               45.00            18                                                     52     O'Donnell DE[@b82-copd-10-667]        354               2004               32.18            38                                                     86     Difrancia M[@b116-copd-10-667]      277               1994               13.19            94
  19     Bestall JC[@b50-copd-10-667]      518               1999               32.38            36                                                     53     Pitta F[@b83-copd-10-667]             347               2005               34.70            32                                                     87     Schols A[@b117-copd-10-667]         275               1996               14.47            88
  20     Buist AS[@b51-copd-10-667]        510               2007               63.75            8                                                      54     Keatings VM[@b84-copd-10-667]         346               1997               19.22            73                                                     88     Rahman I[@b118-copd-10-667]         274               2006               30.44            43
  21     Pauwels RA[@b52-copd-10-667]      501               1999               31.31            39                                                     55     O'Donnell DE[@b85-copd-10-667]        344               2001               24.57            56                                                     89     Sethi S[@b119-copd-10-667]          272               2001               19.43            71
  22     Schols A[@b53-copd-10-667]        484               1998               28.47            48                                                     56     Wiggs BR[@b86-copd-10-667]            343               1992               14.91            84                                                     90     Wedzicha JA[@b120-copd-10-667]      268               2008               38.29            26
  23     Ries AL[@b54-copd-10-667]         482               1995               24.10            57                                                     57     Pauwels RA[@b87-copd-10-667]          342               2004               31.09            41                                                     91     Dekhuijzen PNR[@b121-copd-10-667]   267               1996               14.05            91
  24     Repine JE[@b55-copd-10-667]       457               1997               25.39            55                                                     58     Halbert RJ[@b88-copd-10-667]          337               2006               37.44            27                                                     92     Donohue JF[@b122-copd-10-667]       266               2002               20.46            65
  25     Casaburi R[@b56-copd-10-667]      456               2002               35.08            30                                                     59     Murphy TF[@b89-copd-10-667]           331               1992               14.39            89                                                     93     Nishimura K[@b123-copd-10-667]      263               2002               20.23            66
  26     Mannino DM[@b57-copd-10-667]      440               2007               55.00            9                                                      60     McSweeny AJ[@b90-copd-10-667]         329               1982               9.97             96                                                     94     Menezes AMB[@b124-copd-10-667]      262               2005               26.20            52
  27     Rahman I[@b58-copd-10-667]        432               1996               22.74            59                                                     61     Schols A[@b91-copd-10-667]            327               1993               14.86            85                                                     95     Patel IS[@b125-copd-10-667]         259               2002               19.92            68
  28     Sethi S[@b59-copd-10-667]         431               2002               33.15            34                                                     62     Calverley PM[@b92-copd-10-667]        326               2003               27.17            51                                                     96     O'Donnell DE[@b126-copd-10-667]     259               1998               15.24            82
  29     Plant PK[@b60-copd-10-667]        430               2000               28.67            45                                                     63     Bhowmik A[@b93-copd-10-667]           321               2000               21.40            63                                                     97     Aaron SD[@b127-copd-10-667]         258               2007               32.25            37
  30     Sin DD[@b61-copd-10-667]          428               2003               35.67            29                                                     64     Lopez AD[@b94-copd-10-667]            314               2006               34.89            31                                                     98     Weitzenblum E[@b128-copd-10-667]    258               1981               7.59             99
  31     Seemungal T[@b62-copd-10-667]     428               2000               28.53            47                                                     65     Agusti AGN[@b95-copd-10-667]          309               2003               25.75            54                                                     99     Kanner RE[@b129-copd-10-667]        257               2001               18.36            76
  32     Altose MD[@b63-copd-10-667]       422               2000               28.13            49                                                     66     Traver GA[@b96-copd-10-667]           308               1979               8.56             97                                                     100    Marquis K[@b28-copd-10-667]         254               2002               19.54            70
  33     Vestbo J[@b64-copd-10-667]        414               1999               25.88            53                                                     67     Lambert RK[@b97-copd-10-667]          304               1993               13.82            92                                                                                                                                                      
  34     Vincken W[@b65-copd-10-667]       407               2002               31.31            40                                                     68     Wagner PD[@b98-copd-10-667]           304               1977               8.00             98                                                                                                                                                      

**Note:**

The "new rank" was sorted by the average annual number of citations.

**Abbreviation:** COPD, chronic obstructive pulmonary disease.

###### 

Top-ten sources that contribute most articles to the top-100 papers

  Journal                                                                                    Number
  ------------------------------------------------------------------------------------------ --------
  *American Journal of Respiratory and Critical Care Medicine (Am J Respir Crit Care Med)*   30
  *European Respiratory Journal (Eur Respir J)*                                              14
  *New England Journal of Medicine (N Engl J Med)*                                           12
  *Lancet*                                                                                   10
  *Thorax*                                                                                   8
  *American Review of Respiratory Disease (Am Rev Respir Dis)*                               7
  *Annals of Internal Medicine (Ann Intern Med)*                                             4
  *Chest*                                                                                    3
  *Archives of Internal Medicine (Arch Intern Med)*                                          2
  *Journal of the American Medical Association* (*J Am Med Assoc*)                           2

###### 

Decades distribution of the top-100 most cited papers

  Year     Number   Mean number of citations   Minimum number of citations   Maximum number of citations
  -------- -------- -------------------------- ----------------------------- -----------------------------
  −1980s   8        412                        258                           1,129
  1990s    37       413                        259                           1,006
  2000s    55       481                        254                           2,164

###### 

Countries that contributed more than four papers in the 100 most influential papers

  Country       Number
  ------------- --------
  USA           38
  England       34
  Canada        20
  Netherlands   12
  Italy         10
  Belgium       9
  Spain         8
  Denmark       7
  Australia     6
  Scotland      5

###### 

The top-ten institutions contributing to the most cited articles in COPD

  Institute                          Number
  ---------------------------------- --------
  Imperial College London            16
  University of London               10
  GlaxoSmithKline                    9
  St Georges University London       8
  University of British Columbia     8
  University of California System    8
  Oregon Health Science University   7
  Oregon University System           7
  Queen Mary University London       7
  University of Copenhagen           7

**Abbreviation:** COPD, chronic obstructive pulmonary disease.

###### 

Research field of the most cited articles in COPD

  Field                              Number
  ---------------------------------- --------
  General internal medicine          63
  Respiratory system                 63
  Cardiovascular system cardiology   2
  Immunology                         1
  Microbiology                       1
  Physiology                         1
  Research experimental medicine     1
  Sport sciences                     1
  Surgery                            1

**Abbreviation:** COPD, chronic obstructive pulmonary disease.

###### 

The authors who contribute more than four articles to the top-100 papers

  Author                                                                                                                                                                                                        Number of citation classics   Position on author list
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------- -----------------------------------------------------------------------------------------------
  Barnes PJ[@b24-copd-10-667],[@b40-copd-10-667],[@b45-copd-10-667],[@b47-copd-10-667],[@b68-copd-10-667],[@b78-copd-10-667],[@b84-copd-10-667],[@b99-copd-10-667],[@b101-copd-10-667],[@b104-copd-10-667]      10                            First author -- 4, fourth -- 3, sixth -- 1, seventh -- 1, others -- 1
  Wedzicha JA[@b27-copd-10-667],[@b41-copd-10-667],[@b44-copd-10-667],[@b50-copd-10-667],[@b62-copd-10-667],[@b67-copd-10-667],[@b93-copd-10-667],[@b104-copd-10-667],[@b120-copd-10-667],[@b125-copd-10-667]   10                            First author -- 1, fourth -- 2, fifth -- 1, sixth -- 3, others -- 3
  Vestbo J[@b25-copd-10-667],[@b27-copd-10-667],[@b36-copd-10-667],[@b49-copd-10-667],[@b64-copd-10-667],[@b73-copd-10-667],[@b112-copd-10-667],[@b113-copd-10-667]                                             8                             First author -- 2, second -- 1, third -- 1, fourth -- 1, sixth -- 1, eighth -- 1, others -- 1
  Jones PW[@b36-copd-10-667],[@b42-copd-10-667],[@b49-copd-10-667],[@b50-copd-10-667],[@b56-copd-10-667],[@b100-copd-10-667],[@b104-copd-10-667]                                                                7                             First author -- 1, third -- 2, fifth -- 1, sixth -- 2, others -- 1
  Buist AS[@b24-copd-10-667],[@b25-copd-10-667],[@b51-copd-10-667],[@b57-copd-10-667],[@b88-copd-10-667],[@b110-copd-10-667]                                                                                    6                             First author -- 1, second -- 1, fifth -- 1, sixth -- 2, others -- 1
  Calverley PMA[@b24-copd-10-667],[@b36-copd-10-667],[@b42-copd-10-667],[@b49-copd-10-667],[@b92-copd-10-667],[@b120-copd-10-667]                                                                               6                             First author -- 1, second -- 2, seventh -- 1, ninth -- 1, tenth -- 1
  Hogg JC[@b26-copd-10-667],[@b68-copd-10-667],[@b72-copd-10-667],[@b75-copd-10-667],[@b86-copd-10-667],[@b97-copd-10-667]                                                                                      6                             First author -- 2, fourth -- 1, fifth -- 1, sixth -- 1, tenth -- 1
  Anthonisen NR[@b37-copd-10-667],[@b63-copd-10-667],[@b71-copd-10-667],[@b108-copd-10-667],[@b129-copd-10-667]                                                                                                 5                             First author -- 2, second -- 1, fourth -- 1, others -- 1
  Celli BR[@b25-copd-10-667],[@b35-copd-10-667],[@b36-copd-10-667],[@b99-copd-10-667],[@b112-copd-10-667]                                                                                                       5                             First author -- 3, second -- 1, tenth -- 1
  Maltais F[@b28-copd-10-667],[@b80-copd-10-667],[@b81-copd-10-667],[@b107-copd-10-667],[@b127-copd-10-667]                                                                                                     5                             First author -- 1, third -- 1, fourth -- 1, seventh -- 2
  Seemungal TAR[@b41-copd-10-667],[@b44-copd-10-667],[@b93-copd-10-667],[@b120-copd-10-667],[@b125-copd-10-667]                                                                                                 5                             First author -- 2, second -- 3
